| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/14/2009 | EP1144616B2 Method for producing antibody fragments |
| 01/14/2009 | EP1130029B1 Protein amsh and cdna thereof |
| 01/14/2009 | EP1025218B1 Libraries of human antibody polypetides |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN101346631A Sensing device and method for determination of the amount of target molecule in an analyte |
| 01/14/2009 | CN101346397A Agents that bind a target in pulmonary tissue for treating respiratory diseases |
| 01/14/2009 | CN101346395A Anti-IL-6 antibodies preventing the binding of IL-6 complexed with il-6Ralpha to GP130 |
| 01/14/2009 | CN101346394A TGF-beta binding compositions |
| 01/14/2009 | CN101346153A Immunoglobulin G (IGG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IGGS |
| 01/14/2009 | CN101343623A Hybrid tumor, antihuman bladder cancer monoantibody and guide medicament, and bladder cancer diagnosis agent |
| 01/14/2009 | CN101343325A Antibody preparation method capable of detecting multiple organophosphorus pesticide residuals |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343323A Anti-interleukins-8 antibody |
| 01/14/2009 | CN101343322A Immune method for quickly preparing domoic acid monoclone antibody |
| 01/14/2009 | CN101343321A Novel serotype streptococcus mutans and utilization of the same |
| 01/14/2009 | CN101343320A Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof |
| 01/14/2009 | CN101343319A Anti-dengue virus E protein monoclone antibody, preparation method and uses thereof |
| 01/14/2009 | CN101342368A Antigenized antibody vaccine for foot-and-mouth disease |
| 01/14/2009 | CN100451115C Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 01/14/2009 | CN100451033C Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 01/13/2009 | US7476735 Compounds and methods for labeling oligonucleotides |
| 01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
| 01/13/2009 | US7476724 for identifying and/or using inhibitors of the HGF/c-met signaling pathway; a mesenchyme-derived pleiotrophic factor with mitogenic, motogenic and morphogenic activities on a number of different cell types |
| 01/13/2009 | US7476723 Nucleotide sequences coding membrane protein ; antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/13/2009 | US7476722 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476540 Monoclonal antibodies to mesenchymal stem cells |
| 01/13/2009 | US7476536 Artificial human chromosome containing human antibody a light chain gene |
| 01/13/2009 | US7476509 Compounds and methods for modulating functions of nonclassical cadherins |
| 01/13/2009 | US7476442 Nanoparticle chains and preparation thereof |
| 01/13/2009 | US7476391 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/13/2009 | US7476389 Papillomavirus vaccines |
| 01/13/2009 | US7476385 Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
| 01/13/2009 | US7476384 Death domain containing receptor 4 antibody and methods |
| 01/13/2009 | US7476383 Antiproliferative agent; induction apoptosis; antitumor agents |
| 01/13/2009 | CA2374729C Novel organic anion transport proteins |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009006620A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | WO2009006439A1 Predictive markers for ovarian cancer |
| 01/08/2009 | WO2009006112A1 Mdl-1 uses |
| 01/08/2009 | WO2009005870A2 Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| 01/08/2009 | WO2009005809A2 Compositions and methods for treating and diagnosing cancer |
| 01/08/2009 | WO2009005783A1 Peptides, compositions and methods for reducing beta-amyloid-mediated apoptosis |
| 01/08/2009 | WO2009005726A1 Antigen binding proteins that bind par-2 |
| 01/08/2009 | WO2009005673A1 Anti-igf1r |
| 01/08/2009 | WO2009005040A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 01/08/2009 | WO2009004822A1 ANTI-Muc17 ANTIBODY |
| 01/08/2009 | WO2009003975A1 Antibodies against human cytomegalovirus (hcmv) |
| 01/08/2009 | WO2009003623A1 Heavy chain mutant leading to improved immunoglobulin production |
| 01/08/2009 | WO2009003489A1 CaOU-1 EPITOPE BINDING POLYPEPTIDES |
| 01/08/2009 | WO2008144720A3 Inhibitors of igf-1r signaling for the treatment of respiratory disorders |
| 01/08/2009 | WO2008142693A3 Regulation of myelination by nectin-like (necl) molecules |
| 01/08/2009 | WO2008140653A9 Humaneered anti-factor b antibody |
| 01/08/2009 | WO2008137475A3 Immunoglobulin fc libraries |
| 01/08/2009 | WO2008120202A3 Antibodies, methods and kits for diagnosing and treating melanoma |
| 01/08/2009 | WO2008119567A3 Cross-species-specific cd3-epsilon binding domain |
| 01/08/2009 | WO2008119566A3 Cross-species-specific bispecific binders |
| 01/08/2009 | WO2008119565A3 Cross-species-specific binding domain |
| 01/08/2009 | WO2008116103A3 Stable antibody formulations |
| 01/08/2009 | WO2008091740A4 Polyelectrolyte precipitation and purification of antibodies |
| 01/08/2009 | WO2008079246A3 Cd44 antibodies |
| 01/08/2009 | WO2007143098A8 Hepatocyte growth factor (hgf) binding proteins |
| 01/08/2009 | WO2007117680A3 Methods and compositions for treating bacterial infection |
| 01/08/2009 | WO2007014114A3 Methods for reducing viral load in hiv-1-infected patients |
| 01/08/2009 | US20090012272 Comprise a peptide as an internal sequence; Fc internal peptide molecules; have advantages in refolding and purification over N- or C-terminally linked Fc molecules; increased resistance to proteolytic degradation from amino- and carboxy-peptidases |
| 01/08/2009 | US20090012271 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012269 CC-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders |
| 01/08/2009 | US20090012268 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine |
| 01/08/2009 | US20090012267 Anti-hydroxylase antibodies and uses thereof |
| 01/08/2009 | US20090012024 Stem Cell Markers |
| 01/08/2009 | US20090012020 Inhibiting formation of atherosclerotic lesions |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011983 186 Human Secreted Proteins |
| 01/08/2009 | US20090011974 Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011497 Peptides and related compounds having thrombopoietic activity |
| 01/08/2009 | US20090011487 Production of UGPPase |
| 01/08/2009 | US20090011471 Engineered plasmids and their use for in situ production of genes |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011453 Methods for Producing Proteins Using Hamster Igf-1 |
| 01/08/2009 | US20090011442 TB diagnostics based on mycobacterium tuberculosis excretory secretory antigens and their specific immunoglobulins |
| 01/08/2009 | US20090011434 Methods And Compositions For Diagnosing Breast Cancer |
| 01/08/2009 | US20090011426 Methods of Diagnosis and Treatment of M.Tuberculosis Infection and Reagents Therefor |
| 01/08/2009 | US20090011409 Antibodies Against Cells of Fetal Origin |
| 01/08/2009 | US20090010956 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 01/08/2009 | US20090010945 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 01/08/2009 | US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | US20090010939 Administering a monoclonal anti-CD80 antibody or CD80 binding fragment that binds specifically to human CD80 antigen and inhibits binding of the CD80 antigen to CD28 without inhibiting the binding of the CD80 antigen to CTLA-4; immunosuppressants, autoimmune diseases, transplant rejection |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010934 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010932 Gb virus c (hepatitis g virus) for the treatment of hiv |
| 01/08/2009 | US20090010931 restoring growth inhibition sensitivity to a tumor cell resistant to growth inhibition by HER2 antagonists; antibody produced by the hybridoma 4F10; PC-Cell Derived Growth Factor (PCDGF) |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010928 Anti-anthrax antibody, formulations thereof, and methods of use |